Replies to post #268658 on Amarin Corp Plc (AMRN)

[invest2992]

Thanx tuc. Scripts aren’t too bad given the C19 shut down. At least refills are up strong. Now if we can begin to open up Dr. offices we could write some new scripts. Thanx again.

[Invest83838]

Thank You tucaman

Very bothersome that Generic Lovaza is tracking well with Vascepa

Apparently Amarin not making any headway

against the doctors, pharmacists, and/or insurance companies

prescribing/providing Generic Lovaza instead of Vascepa

[Restingzebra]

Thank you! All things considered, scripts are holding up. Stay healthy and thanks again.

[rosemountbomber]

Appreciate you getting us these script numbers. Stay well and have a great weekend.

[circuitcity]

Thanks a lot for the reports.

[sts66]

Damn - TRx down -10% in the 3 weeks since 3/30, NRx down -12% - lousy start to Q2 sales because of the damn virus. I expect that trend to worsen before it turns around, which might not even be by Q3 - cash burn is probably going to be higher than we expected unless they really slow walk the DTC campaign - heck, they shouldn't even roll it out when most people can't see their docs and while reps are grounded. Speaking of which, the pandemic might change rep access to docs permanently - many behavioral changes made to avoid spreading the virus are expected to become the new way of life.

[tucaman]

Scripts for week ending 04/24/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Vascepa
TRx: 82'818 (+1.88%)
NRx: 35'821 (+2.90%)

Generic Lovaza
TRx: 59'667 (-0.14%)
NRx: 27'750 (+1.52%)